Maxim Group analyst Naz Rahman maintained a Hold rating on 9 Meters Biopharma (NMTR - Research Report) yesterday. The company's shares opened today at $0.30.According to TipRanks, Rahman is an analyst with an average return of -25.9% and a 26.67% success rate. Rahman covers the Healthcare sector, focusing on stocks such as Vertex Pharmaceuticals, 9 Meters Biopharma, and Virpax Pharmaceuticals.9 Meters Biopharma has an analyst consensus of Strong Buy, with a price target consensus of $3.25.See the top stocks recommended by analysts >>Based on 9 Meters Biopharma's latest earnings release for the quarter ending March 31, the company reported a quarterly GAAP net loss of $11.35 million.
https://www.tipranks.com/news/blurbs/maxim-group-keeps-their-hold-rating-on-9-meters-biopharma-nmtr?utm_source=advfn.com&utm_medium=referral
9 Meters Biopharma (NASDAQ:NMTR)
Historical Stock Chart
From Nov 2022 to Dec 2022 Click Here for more 9 Meters Biopharma Charts.
9 Meters Biopharma (NASDAQ:NMTR)
Historical Stock Chart
From Dec 2021 to Dec 2022 Click Here for more 9 Meters Biopharma Charts.